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TJ{EORETICAL CONSIDERATIONS
It is generally accepted that histamine, or a histamine-like substance plays a role in the
pathogenesis of urticaria. Among so called "anti-histaminie agents," Benadryl and Pyri-
benzamine have received extensive clinical and experimental trial in this country. It
is now recognized that in many cases both these agents act as inhibitors of the urticarial
response.
The role of histamine in other types of allergic skin reactions, such as the tuberculin-
type response and eczematous response to patch tests is questionable.
Boquet (1) investigating some of the experimental forerunners of Benadryl and Pyri-
benzamine, 2339 RP, 929 F, and 883 F, found that large doses, given subcutaneously, did
not protect sensitized guinea pigs against crude tuberculin, nor did they mitigate the local
response of such animals to intracutaneous injections of tuberculin. Breton's (2) experi-
ments with human subjects, in which he compared the response to tuberculin patch tests
applied over wheals produced by intracutaneous injections of 2339 lIP with those applied
over normal skin, indicate that this substance did not tend to diminish the response to
tuberculin. More recent investigations (3) in sensitized laboratory animals indicate that
certain phases of other allergic reactions of the delayed eczematous type may be influenced
by anti-histaminic agents. It therefore seemed of practical as well as theoretical interest
to investigate the effects of these new drugs on the various types of delayed allergic skin
reactions in man. The present report deals with the effects of Pyribenzamine on tuberculin
reactions of human skin.
PROCEDURE
In order to appraise the influence of Pyribenzamine on tuberculin reactions, it was neces-
sary first to select subjects whose level of sensitivity to tuberculin could be shown to be
stable, i.e., who would respond with approximately the same degree of reaction to repeated
tests. For this purpose 22 adult subjects were skin tested by intracutaneous injection of
0.1 cc. of Old Tuberculin (Koch) in dilutions of 1:1,000,000; 1:100,000; 1:10,000 and 1:1,000.
To insure uniform conditions of testing, the same observer, i.e., the author, gave all injec-
tions and made all readings of reactions. Throughout the testing the same needle and sy-
ringe were reserved and used for each particular dilution of tuberculin. All dilutions were
freshly prepared every two weeks and were kept under refrigeration. In estimating the
reactions the diameter of the papule and intensity of the inflammation were used as criteria
of the degree of response.
The four serial dilutions were injected in each test series, and the test series were per-
formed at least one week apart. Only those subjects who showed no significant degree
of variation in their response to three consecutive series were selected for studies with Pyri-
benzamine. It was found that stability in the level of skin sensitivity to tuberculin was
the exception rather than the rule. Of 22 subjects tested, only 5 showed what were consi-
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dered a constant degree of sensitivity. After they had demonstrated approximately equal
quantitive responses to three consecutive series of tuberculin tests, these 5 subjects were
give a fourth series of tuberculin tests. But this time, 1 hour before the injection of the
tuberculin, 150 mgm. of Pyribenzamine was given to each subject by mouth. During
the 48 hours following the injection, each subject received a total of 650 mgm. of Pyriben-
zamine in divided doses. The tuberculin tests were then read.
RESULTS
As shown in the accompanying graphs (fig. 1), the drug had no regularly significant
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FIG. 1. GRAPHICAL REPRESENTATION OF RESULTS ON SUBJECTS TREATED WITH
PYRIBENZAMINE
Where blocks of a given dilution are not set down in a given test, the subject was negative
to that dilution of tuberculin.
DISCUSSION
In these experiments the dosage and method of administration of the Pyribenzamine
were chosen in the endeavor to get the maximum effect possible under the particular condi-
tions. The experiments of Baer and Sulzberger (4) have shown that inhibitory effect
of Pyribenzamine on urticarial responses can be demonstrated if the drug is administered
at least one hour before the testing. In the present studies, 400 mgm. of Pyribeazamine
per day was considered a suitable dose, or at least the largest that could safely be given to
ambulatory patients. It was attempted to report the effect of the drug on those features of
the tuberculin response which could be most accurately and objectively measured, namely
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the diameter of the papule and intensity of the inflammation. As a matter of fact, there
appeared to be no significant effects upon any other features of the reactions. Since this
was so, no attempt was made to study changes in histology.
CONCLUSIONS
1. Pyribenzamine, under conditions of the present experiments, had no effect on the
degree of the 48-hour skin reactions to intracutaneous injections of Old Tuberculin (Koch).
2. These results do not negate the possibility that Pyribenzamine, (e.g., in larger dosages
or with administration under a different schedule) or related drugs which may be developed,
might exert an influence on the tuberculin reaction.
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